AMPLEXA GENETICS A/S: Financial statements 2015
CVR: 29428441
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
AMPLEXA GENETICS A/S (CVR 29428441) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 157,496 and a net result of DKK -3,373,569 compared with DKK -3,386,966 the year before. Equity in the 2015 report amounted to DKK -19,582,406.
- Gross Profit
- DKK 157,496
- Profit/Loss
- DKK -3,373,569
- Equity
- DKK -19,582,406
- Total Assets
- DKK 2,308,712
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 157 t. | -3.4 mio. | -19.6 mio. | - |
| 2014 | - | -186 t. | -3.4 mio. | -16.2 mio. | - |
| 2013 | - | -786 t. | -5.9 mio. | -12.8 mio. | - |
| 2012 | - | -538 t. | -2.1 mio. | -7 mio. | - |
Official annual report
How creditworthy is AMPLEXA GENETICS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of November 2, 2015, Johan Jan Albinus Dahl has joined the board of directors of AMPLEXA GENETICS A/S.
As of September 30, 2015, Jørn Kildegaard Andersen has left the board of directors of AMPLEXA GENETICS A/S.
As of May 31, 2015, Leif Mosekilde has left the board of directors of AMPLEXA GENETICS A/S.
AMPLEXA GENETICS A/S has published its annual report for 2014. Gross profit came to DKK -185,712, and the net result was DKK -3,386,966.
About AMPLEXA GENETICS A/S
AMPLEXA GENETICS A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Hans Atli Eli Albinus Dahl. The board consists of Magnus Herdalur (chair), Eydfinn Reydberg and Ulf Bech Christensen. The company is owned by SCIENT. INVEST ApS, Conseco P/F and Sp/f D65 Holding. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 4,009,035 and a net result of DKK -1,583,233 compared with DKK -11,108,344 the year before. Equity in the 2025 report amounted to DKK -10,313,267.